Close Menu

NEW YORK (GenomeWeb) – Is it possible to craft a framework for regulating diagnostics that pleases everyone? A small group of labs and test manufacturers has taken a shot at it by coming up with its own proposal for regulating so-called in vitro clinical tests that it hopes will be an acceptable compromise for industry players that often disagree on the regulation of laboratory-developed tests (LDTs).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports that vaccine developers won't have to conduct large trials of updated vaccines or vaccine boosters aimed at new viral variants.

The SARS-CoV-2 variant uncovered in California may be more transmissible and partially evade vaccine-induced antibody response, the Los Angeles Times reports.

Francis deSouza, the CEO of Illumina, calls for a global SARS-CoV-2 genomics surveillance network, according to the Financial Times.

In PNAS this week: immunotherapy for hard-to-treat breast cancers, effects of oncogenic histone H3K36M mutations, and more.